Background: The quality of the environment within buildings is a topic of major importance for public health. Breathing pure and clean air allows us to think more clearly, sleep more soundly, and stay healthier. Studies show that we receive 56% of our energy from the air we breathe, more than from water and food combined. On average we breathe 37 pounds of air a day. It has been established that the use of negative ions in a purification system is an effective means of eradicating aeroallergens in room air. Methods: The wall-mount, Inducts and Mobile Sanifier air purification units of Luna are designed to sanitize air, to kill surface mold, bacteria, and viruses in areas up to 26,000 cubic feet. Samples were collected from the clinic rooms to analyze the VOC concentrations using the Luna air purifiers to detect the efficiency in reducing the VOCs in the indoor air. We analyzed the aroallergens and VOCs prevalent in the indoor air in the clinics at the Coulter Animal Hospital, Amarillo, Texas. The data were correlated to the inhalant allergy index before and after running air purifiers that use PCO technology. Results: Samples from the clinic rooms to analyze the VOC concentrations using the Luna air purifiers to detect the efficiency in reducing the VOCs in the indoor air. The SKC Pocket Pump and thermal desorption tubes were used to obtain the samples from the indoor air. Pumps were set on 200 mL/min as air flow to estimate the concentration of Acetic acid, Isobutyric acid, Butyric acid, Isovaleric acid, Valeric acid, Hexanoic acid, Phenol, p-cresol, 4-ethyl, 2-amino, Indole, and Skatole. All desorption tube samples were analyzed using a Markes UNITY and Markes Ultra automated thermal desorber (ATD) and a Varian 3800/Saturn 2000 GC with a MS. Slides with double sticky tape were exposed to room air stained with 2% safranin and were observed using a BX-40 Olympus microscope with DP-70 and Image Pro Plus software. Conclusions: The data were correlated with the aeroallergen index and the frequency of inhalant allergy cases that showed reduction in allergic rhinitis index on using air purifiers.
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The Missing Link!! Specialist Nurse-Led Education for Parents of Children With Atopic Eczema Deryn Thompson, RN BNg. Allergy and Dermatology Outpatients, Children's Youth and Women's Health Service, North Adelaide, Australia. Background: Australia's rate of children with food allergy is still on an upward trend. In infants the earliest manifestation is usually atopic eczema. Australian Bureau of Statistics National Health Survey (ABNHS, 2007 (ABNHS, -2008 reported hayfever, allergic rhinitis and asthma in the top 10 most commonly reported long-term conditions for children and young people. Early effective management of eczema is essential. Australia's medical model means long wait for allergy appointments with a specialist, limiting review appointment availability. Following diagnosis of atopic eczema and treatment recommendations by a clinical immunologist/allergist or dermatologist, parents report having many unanswered questions -contributing to anxiety and confusion. They feel overwhelmed that eczema is incurable and longterm management and constant vigilance is required. Many feel a lack of support and despair. Education, demonstration and support by a nurse specialist in eczema management at a Children's hospital in Adelaide has improved outcomes and reduced the psychosocial burden of the condition. Parents and children receive 30 minutes explanation, demonstration of required treatments and an individualised, written eczema action/care plan. The education sessions use a conceptual framework based on Social Cognitive Theory where active participation, goal setting and forward planning enhance understanding assisting the long-term behavioural changes needed to master eczema management effectively. The families are reviewed by the nurse several weeks later to review progress and answer questions that have arisen over the preceding weeks. The education sessions are tailored to the individual family needs, encourage self-management and aim for increased confidence to self-regulate the condition as it waxes and wanes. Methods: Twenty-two families in a novel clinic at Children's Youth and Women's Health Service, Adelaide undertook a pre-post intervention questionnaire surveys. 2 Faculty of Medicine University of Southampton, MSc Allergy, Southampton, United Kingdom. Background: Sublingual immunotherapy (SLIT) using grass pollen extracts is an attractive treatment option compared with subcutaneous immunotherapy (SCIT) for children suffering with the symptoms of seasonal allergic rhinoconjunctivitis, with or without asthma. However, evidence for the efficacy of SLIT in children remains unclear. The objective was to undertake a systematic review of the available literature to identify high quality paediatric studies of SLIT for grass pollen allergy to assess the safety and benefits of SLIT compared with standard medication alone. Methods: MEDLINE, EMBASE, CINAHL, NHSEED, DARE and Cochrane were searched from 1st Jan 2000 to June 2010. A pre-specified inclusion criteria was used to select studies, which were assessed for the risk of bias using the Jadad scale. The outcomes of interest were data from the studies including the reduction of nasal, eye and chest symptoms, use of symptom relieving medication and safety. Results: Nine studies met the inclusion criteria. A narrative synthesis on the safety of SLIT found a high incidence of mild, adverse events. Outcomes were pooled using Rev Man 5 and the random effects model. Inter-study heterogeneity was measured using the I 2 statistic and was ,70% in all metaanalyses. The reduction of total allergic rhino-conjunctivitis symptom scores indicated a small highly significant reduction with non-significant heterogeneity. (SMD -0.24, 95%, CI-0.38 to -0.11 P ¼ 0.0005), (I 2 15% P ¼ 0.32). The reduction in total relief medication use scores compared to placebo was non-significant. (SMD-0.25 CI -0.50, 0.01, P ¼ 0.06). I 2 67% (P ¼ 0.006). Conclusions: SLIT has a small benefit on symptoms but does not demonstrate a significant reduction in medication use. This justifies current SLIT use in paediatric allergy in the UK where availability is limited to children who remain symptomatic despite having proven concordance using 
